The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters
Abstract
Proinflammatory cytokines and serotonergic homeostasis have both been implicated in the pathophysiology of major psychiatric disorders. We have demonstrated that activation of p38 mitogen-activated protein kinase (MAPK) induces a catalytic activation of the serotonin transporter (SERT) arising from a reduction in the SERT Km for 5-hydroxytryptamine (5-HT). As inflammatory cytokines can activate p38 MAPK, we hypothesized that they might also activate neuronal SERT. Indeed, Interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) stimulated serotonin uptake in both the rat embryonic raphe cell line, RN46A, and in mouse midbrain and striatal synaptosomes. In RN46A cells, IL-1beta stimulated 5-HT uptake in a dose- and time-dependent manner, peaking in 20 min at 100 ng/ml. This was abolished by IL-1ra (20 ng/ml), an antagonist of the IL-1 receptor, and by SB203580 (5 microM), a p38 MAPK inhibitor. TNF-alpha also dose- and time-dependently stimulated 5-HT uptake that was only partially blocked by SB203580. Western blots showed that IL-1beta and TNF-alpha activated p38 MAPK, in an SB203580-sensitive manner. IL-1beta induced an SB203580-sensitive decrease in 5-HT Km with no significant change in Vmax. In contrast, TNF-alpha stimulation decreased 5-HT Km and increased SERT Vmax. SB203580 selectively blocked the TNF-alpha-induced change in SERT Km. In mouse midbrain and striatal synaptosomes, maximal stimulatory effects on 5-HT uptake occurred at lower concentrations (IL-1beta, 10 ng/ml; TNF-alpha, 20 ng/ml), and over shorter incubation times (10 min). As with RN46A cells, the effects of IL-1beta and TNF-alpha were completely (IL-1beta) or partially (TNF-alpha) blocked by SB203580. These results provide the first evidence that proinflammatory cytokines can acutely regulate neuronal SERT activity via p38 MAPK-linked pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, inflammatory cytokines, including IL-6, have been shown to increase 5-HTT expression and function (Morikawa et al., 1998, Mossner et al., 1998, Sakai et al., 2003, Tsao et al., 2008) (see Figure 1), an effect found to be mediated by induction of p38 mitogen-activated protein kinase (MAPK), both in vitro and in vivo (Zhu et al., 2005, Zhu et al., 2006, Zhu et al., 2010a).”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Zhu et al., 2006
In the citing paper
“Cytokines also influence the synthesis of monoamines through disruption of tetrahydrobiopterin, an essential enzyme co-factor to hydroxylases involved in monoamine synthesis.”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [89]
In the citing paper
“Furthermore, they can modulate serotonin signaling by increasing the expression and function of monoamine transporters which perform the re-uptake of synaptic serotonin (89–92).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [89]
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985 · cited 1×
“Similarly, short-term exposure of hippocampal neurons to TNF-a (15–30 min) has been found to induce endocytosis of GABA-A receptors and increase trafficking of excitatory AMPA receptors to the plasma membrane (Stellwagen et al, 2005).”
BackgroundcDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily
Sims, J. E., March, C. J., Cosman, D. J., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., et al. (1988) · Science · doi:10.1126/science.2969618 · Cited by 877
Cytokine‐Induced Sickness Behavior: Mechanisms and Implications
Dantzer, R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05827.x · Cited by 825
Psychopharmacology: The Fourth Generation of Progress
Kramlinger, K. G. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.10.1021-a · Cited by 779
Interleukin-1 Immunoreactive Innervation of the Human Hypothalamus
Breder, C. D., Dinarello, C. A., & Saper, C. B. (1988) · Science · doi:10.1126/science.3258444 · Cited by 755
Brockhaus, M., Schönfeld, H., Schlaeǵer, E.-J., Hunziker, W. H., Lesslauer, W., & Loetscher, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3127 · Cited by 649
Li, Y.-P., Chen, Y., John, J., Moylan, J. S., Jin, B., Mann, D. L., & Reid, M. B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2364com · Cited by 634
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 547
Ifuku, M., Hossain, S., Noda, M., & Katafuchi, T. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12668 · Cited by 51
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
Ritsner, M. S. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5 · Cited by 50
Martín‐Hernández, D., Caso, J. R., Bris, Á. G., Maus, S. R., Madrigal, J. L. M., García‐Bueno, B., MacDowell, K. S., Alou, L., Gómez-Lus, M. L., & Leza, J. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.003 · Cited by 55
Filipović, D., Stanisavljević, A., Jasnic, N. I., Bernardi, R. E., Inta, D., Perić, I., & Gass, P. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.020 · Cited by 49
Tsao, C. ‐., Lin, Y.-S., Cheng, J.-T., Lin, C.-F., Wu, H., Wu, S. ‐., & Tsai, W.-H. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107082951 · Cited by 51
Gay, F., Roméo, B., Martelli, C., Benyamina, A., & Hamdani, N. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113735 · Cited by 52
Steiner, J. A., Carneiro, A. M., Wright, J., Matthies, H. J. G., Prasad, H. C., Nicki, C. K., Dostmann, W. R., Buchanan, C. C., Corbin, J. D., Francis, S. H., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-26 · Cited by 48
Self-citationNeuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
Pisanu, A., Boi, L., Mulas, G., Spiga, S., Fenu, S., & Carta, A. R. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1874-4 · Cited by 49
c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s Diseases
Rehfeldt, S. C. H., Majolo, F., Goettert, M. I., & Laufer, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249677 · Cited by 47
Hersey, M., Woodruff, J. L., Maxwell, N., Sadek, A. T., Bykalo, M. K., Bain, I., Grillo, C. A., Piroli, G. G., Hashemi, P., & Reagan, L. P. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.010 · Cited by 48
Molecular networks of brain and immunity
Goncharova, L. B., & Tarakanov, A. O. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.003 · Cited by 48
van Heesch, F., Prins, J., Konsman, J. P., Korte-Bouws, G. A. H., Westphal, K. G. C., Rybka, J., Olivier, B., Kraneveld, A. D., & Korte, S. M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.014 · Cited by 47
Robson, M. J., Zhu, C.-B., Quinlan, M. A., Botschner, D. A., Baganz, N. L., Lindler, K. M., Thome, J. G., Hewlett, W. A., & Blakely, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150068 · Cited by 47
Self-citationDepression in breast cancer patients: Immunopathogenesis and immunotherapy
Yu, S., Li, W., Tang, L., Fan, X., Yao, S., Zhang, X., Bi, Z., & Cheng, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215648 · Cited by 51
van Heesch, F., Prins, J., Konsman, J. P., Westphal, K. G. C., Olivier, B., Kraneveld, A. D., & Korte, S. M. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.013 · Cited by 46
Wang, M., Gui, X., Wu, L., Tian, S., Wang, H., Xie, L., & Wu, W. (2020) · BMC Neurology · doi:10.1186/s12883-020-01780-7 · Cited by 46
Fu, X., Lawson, M. A., Kelley, K. W., & Dantzer, R. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-88 · Cited by 45
Yao, L., Pan, L., Qian, M., Sun, W., Chun-hong, G., Chen, L., Tang, X., Hu, Y., Xu, L., Wei, Y., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.518837 · Cited by 46
Stewart, A. M., Roy, S., Wong, K., Gaikwad, S., Chung, K. M., & Kalueff, A. V. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.037 · Cited by 44
Correia, A. S., Cardoso, A., & Vale, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168525 · Cited by 46
Brüning, C. A., Martini, F., Soares, S. M., Savegnago, L., Sampaio, T. B., & Nogueira, C. W. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.019 · Cited by 43
Nichols, C. D. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/475108 · Cited by 43
Stress to inflammation and anhedonia: Mechanistic insights from preclinical and clinical models
Boyle, C. C., Bower, J. E., Eisenberger, N. I., & Irwin, M. R. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105307 · Cited by 45
Анатольевич, П. И., Cline, B. H., Anthony, D. C., Steinbusch, H. W. M., Lesch, K., & Strekalova, T. V. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.049 · Cited by 45
Kim, E.-A. L., Han, A. R., Choi, J.-Y., Ahn, J., Choi, S. Y., & Cho, S. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.06.022 · Cited by 42
Grygiel‐Górniak, B., Limphaibool, N., & Puszczewicz, M. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12826 · Cited by 46
Metaxas, A., Anzalone, M., Vaitheeswaran, R., Petersen, S., Landau, A. M., & Finsen, B. R. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0491-2 · Cited by 44
Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia
Molfino, A., Gioia, G., Fanelli, F. R., & Laviano, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/801685 · Cited by 42
Felger, J. C., Alagbe, O., Pace, T. W. W., Woolwine, B. J., Hu, F., Raison, C. L., & Miller, A. H. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.015 · Cited by 41
“Moreover, these data are consistent with a potential impact of p38 pathways on behavior through effects on the serotonin transporter (Zhu et al. 2006; Zhu et al. 2010) and the GR (Wang et al.”
BackgroundMethodThe role of immunomodulators in treatment-resistant depression: case studies
Beckett, C. W., & Niklison-Chirou, M. V. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01147-6 · Cited by 43
Lee, S., Chen, S., Chang, Y.-H., Chen, P. S., Huang, S., Tzeng, N., Wang, Y., Wang, L., Lee, I. H., Wang, T.-Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066847 · Cited by 43
The effects of Sceletium tortuosum in an in vivo model of psychological stress
Smith, C. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.08.058 · Cited by 41
Woo, Y. S., Lim, H. K., Wang, S., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186969 · Cited by 43
Stress circuitry: mechanisms behind nervous and immune system communication that influence behavior
Tong, R. L., Kahn, U. N., Grafe, L. A., Hitti, F. L., Fried, N. T., & Corbett, B. F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1240783 · Cited by 44
Saggu, S., Pless, A., Dew, E., Ware, D., Jiao, K., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543730 · Cited by 45
The inflammatory cytokines: molecular biomarkers for major depressive disorder?
Martin, C., Tansey, K. E., Schalkwyk, L. C., & Powell, T. R. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.29 · Cited by 42
Pesarico, A. P., Sartori, G., Brüning, C. A., Mantovani, A. C., Duarte, T., Zeni, G. R., & Nogueira, C. W. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.03.049 · Cited by 42
Jiao, J., Cheng, C., Ma, Y.-J., Huang, J., Dai, M.-C., Jiang, C., Wang, C., & Shao, J.-F. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3494 · Cited by 40
Todorović, N., & Filipović, D. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.10.006 · Cited by 41
Ferencová, N., Višňovcová, Z., Ondrejka, I., Funakova, D., Hrtánek, I., Kelčíková, S., & Tonhajzerová, I. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s387588 · Cited by 39
Xing, B., Bachstetter, A. D., & Eldik, L. J. V. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0372-x · Cited by 39
Steinbusch, H. W. M., Dolatkhah, M. A., & Hopkins, D. A. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.02.003 · Cited by 38
Izumi, H., Sato, K., Kojima, K., Saito, T., Saido, T. C., & Fukunaga, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108026 · Cited by 37
Schmidt, F. M., Kirkby, K. C., & Himmerich, H. (2014) · PubMed · Cited by 37
The Neuro‐Immune Axis: Prospect for Novel Treatments for Mental Disorders
Kraneveld, A. D., de Theije, C. G. M., van Heesch, F., Borre, Y. E., de Kivit, S., Olivier, B., Korte, S. M., & Garssen, J. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12154 · Cited by 38
Gao, H., Zhu, X., Xi, Y., Li, Q., Shen, Z., & Yang, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5517 · Cited by 37
Biological correlates of treatment resistant depression: a review of peripheral biomarkers
Mancuso, E., Sampogna, G., Boiano, A., Rocca, B. D., Vincenzo, M. D., Lapadula, M. V., Martinelli, F., Lucci, F., & Luciano, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1291176 · Cited by 42
Baganz, N. L., Lindler, K. M., Zhu, C.-B., Smith, J., Robson, M. J., Iwamoto, H., Deneris, E. S., Hewlett, W. A., & Blakely, R. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.168 · Cited by 36
Self-citationKorte-Bouws, G. A. H., Albers, E., Voskamp, M. J., Hendriksen, H., de Leeuw, L. R., Güntürkün, O., de Roock, S., Vastert, S. J., & Korte, S. M. (2019) · Pharmaceuticals · doi:10.3390/ph12010009 · Cited by 37
Role of luteolin in overcoming Parkinson's disease
Siddique, Y. H. (2021) · BioFactors · doi:10.1002/biof.1706 · Cited by 36
Genetic factors affecting susceptibility to alcoholic liver disease in an Indian population
Dutta, A. K. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31295-5 · Cited by 37
Zhang, J., Yue, Y., Thapa, A., Fang, J., Zhao, S., Shi, W., Yang, Z. H., Li, Y., & Yuan, Y. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.03.001 · Cited by 36
Antunes, M. S., Ruff, J. R., Janner, D. E., Piêgas, M. B., de Brito, M. L. O., Rocha, K. M. A., de Gomes, M. G., Goes, A. T. R., Souza, L. C., Donato, F., et al. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.05.018 · Cited by 34
Tadić, A. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2262 · Cited by 37
Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders
Kalinichenko, L. S., Kornhuber, J., & Müller, C. P. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100783 · Cited by 35
Cavanagh, J., Paterson, C., McLean, J., Pimlott, S. L., McDonald, M., Patterson, J., Wyper, D. J., & McInnes, I. B. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.107912 · Cited by 34
Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation
Howerton, A. R., Roland, A. V., & Bale, T. L. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0118-14.2014 · Cited by 33
Arısoy, Ö., Beş, C., Cifci, C., Sercan, M., & Soy, M. (2013) · Rheumatology International · doi:10.1007/s00296-013-2671-x · Cited by 33
Major depressive disorders accompanying autoimmune diseases – Response to treatment
Białek, K. I., Czarny, P. L., Strycharz, J., & Śliwiński, T. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109678 · Cited by 34
Birmann, P. T., Sousa, F. S. S., Domingues, M., Brüning, C. A., Vieira, B. M., Lenardao, E. J., & Savegnago, L. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.04.014 · Cited by 32
Demin, K. A., Kolesnikova, T. O., Galstyan, D. S., Krotova, N. A., Ilyin, N. P., Derzhavina, K. A., Levchenko, N. A., Strekalova, T. V., de Abreu, M. S., Petersen, E. V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92422-6 · Cited by 33
The sex-dependent response to psychosocial stress and ischaemic heart disease
Helman, T. J., Headrick, J. P., Stapelberg, N. J. C., & Braidy, N. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1072042 · Cited by 36
Mazalouskas, M. D., Jessen, T. N., Varney, S., Sutcliffe, J. S., Veenstra-VanderWeele, J. M., Cook, E. H., & Carneiro, A. M. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.51 · Cited by 31
Anti-Inflammatory Drugs in Psychiatry
Berthold‐Losleben, M., Heitmann, S., & Himmerich, H. (2009) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152809789352221 · Cited by 32
Comorbidity of depressive and dermatologic disorders - therapeutic aspects.
Filaković, P., Petek, A., Koić, O., Radanović-Grgurić, L., & Degmečić, D. (2009) · PubMed · Cited by 31
Mir363-3p attenuates post-stroke depressive-like behaviors in middle-aged female rats
Panta, A., Pandey, S., Duncan, I. N., Duhamel, S., & Sohrabji, F. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.003 · Cited by 31
Hu, Y., Ehli, E. A., Hudziak, J. J., & Davies, G. E. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.24 · Cited by 31
Inamdar, A., Merlo‐Pich, E., Gee, M., Makumi, C. W., Mistry, P. C., Robertson, J., Steinberg, E., Zamuner, S., Learned, S. M., Alexander, R., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114529377 · Cited by 30
Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders
Perrone, M. G., Centonze, A., Miciaccia, M., Ferorelli, S., & Scilimati, A. (2020) · Molecules · doi:10.3390/molecules25225388 · Cited by 31
Strekalova, T. V., Pavlov, D., Трофимов, А. Н., Anthony, D. C., Svistunov, A. A., Proshin, A. T., Umriukhin, A., Lyundup, A. V., Lesch, K., & Cespuglio, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042061 · Cited by 31
Genetic biomarkers of depression
Tamatam, A., Bawa, A. S., & Khanum, F. (2012) · Indian journal of human genetics · doi:10.4103/0971-6866.96639 · Cited by 32
Zhu, C.-B., Lindler, K. M., Campbell, N. G., Sutcliffe, J. S., Hewlett, W. A., & Blakely, R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071399 · Cited by 30
Self-citationStudy on the Mechanism for SIRT1 during the Process of Exercise Improving Depression
Qiu, X., Lu, P., Zeng, X., Jin, S., & Chen, X. (2023) · Brain Sciences · doi:10.3390/brainsci13050719 · Cited by 33
Miaskowski, C. A., Cataldo, J. K., Baggott, C., West, C. M., Dunn, L. B., Dhruva, A., Merriman, J. D., Langford, D. J., Kober, K. M., Paul, S. M., et al. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2443-5 · Cited by 30
Hassan, M.-A. M., Gad, A. M., Menze, E. T., Badary, O. A., & El‐Naga, R. N. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114140 · Cited by 29
Zhao, H., Liu, J., Song, L., Liu, Z., Han, G., Yuan, D., Wang, T., Dun, Y., Zhou, Z., Liu, Z., et al. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12668 · Cited by 29
Lau, T., Horschitz, S., Bartsch, D., & Schloss, P. D. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.004 · Cited by 29
Kwon, S., Lee, B., Yeom, M., Sur, B., Kim, M., Kim, S.-T., Park, H., Lee, H., & Hahm, D. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.009 · Cited by 29
Pinna, A., Costa, G., Serra, M., Contu, L., & Morelli, M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108693 · Cited by 28
Krishnadas, R., Krishnadas, R., & Cavanagh, J. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-112 · Cited by 28
Mansour, A., Mohamed, B. M. S. A., Aboul‐Fotouh, S., Ibrahim, E. A.-S., Shehata, H., Yassin, N., El‐Eraky, W. I., & Abdel-Tawab, A. M. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41020 · Cited by 29
Department of Psychological Medicine, K. C. L., Hussein, S., Himmerich, H., Department of Psychiatry, P. A. P., Willmund, G. D., Department of Psychiatry, P. A. P., Ibrahim, M. A. A., Department of Immunological Medicine and Allergy, K. H. P., Dalton, B., & Department of Psychological Medicine, K. C. L. (2017) · Psychiatria Danubina · doi:10.24869/psyd.2017.407 · Cited by 26
Han, Y., Sun, C.-Y., Meng, S., Tabarak, S., Yuan, K., Cao, L., Yan, W., Xu, L., Deng, J., Zhu, W., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0470-9 · Cited by 25
Research progress on rheumatoid arthritis-associated depression
Liu, N., Yan, W., Su, R., Zhang, L., Wang, X., Li, Z., Qin, D., & Peng, J. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.992223 · Cited by 33
Sáiz, P. A., García‐Portilla, M. P., Paredes, B., Corcoran, P. E., Arango, C., Morales, B., Sotomayor, E., Álvarez, V., Coto, E., Flórez, G., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.04.011 · Cited by 28
Alozie, E. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608059768115010014 · Cited by 26
Astrocytic TNFα regulates the behavioral response to antidepressants
Duseja, R., Heir, R., Lewitus, G. M., Altimimi, H. F., & Stellwagen, D. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.012 · Cited by 25
Almulla, A. F., & Maes, M. H. J. (2025) · CNS Drugs · doi:10.1007/s40263-025-01195-3 · Cited by 29
Shared Genetic Risk Factors for Late-Life Depression and Alzheimer’s Disease
Ye, Q., Bai, F., & Zhang, Z. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151129 · Cited by 26
Lin, Y., Wang, H.-L., Lu, K., Huang, Y., Panyod, S., Liu, W.-T., Yang, S., Chen, M.-H., Lu, Y., & Sheen, L. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113395 · Cited by 26
Rengasamy, M. L., Marsland, A. L., Spada, M. L., Hsiung, K. S., Kovats, T., & Price, R. B. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100177 · Cited by 29
Depression, Strokes and Dementia: New Biological Insights into an Unfortunate Pathway
Hakim, A. M. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/649629 · Cited by 26
Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia
Eller, T., Aluoja, A., Maron, E., & Vasar, V. (2009) · Medicina · doi:10.3390/medicina45120124 · Cited by 25
Zheng, Y., & Xu, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1646740 · Cited by 25
Microbiome‐skin‐brain axis: A novel paradigm for cutaneous wounds
Hadian, Y., Fregoso, D. R., Nguyen, C., Bagood, M. D., Dahle, S. E., Gareau, M. G., & Isseroff, R. R. (2020) · Wound Repair and Regeneration · doi:10.1111/wrr.12800 · Cited by 26
Zhang, Y., Li, X., Zhou, K., Zhou, M.-K., Xia, K., Xu, Y., Sun, X.-Z., Zhu, Y., Cui, C., & Deng, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574212 · Cited by 23
Vo, V.-T., Phung, V., & Lee, S. (2021) · Surfaces and Interfaces · doi:10.1016/j.surfin.2021.101181 · Cited by 23
Zailani, H., Satyanarayanan, S. K., Liao, W.-C., Liao, H.-F., Huang, S., Gałecki, P., Su, K., & Chang, J. P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072653 · Cited by 24
Neuroimmune modulation by tryptophan derivatives in neurological and inflammatory disorders
Kondo, T., Okada, Y., Saika, S., Yamaguchi, N., Hatakeyama, S., & Maruyama, K. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151418 · Cited by 24
Gómez-Lázaro, E., Garmendia, L., Beitia, G., Pérez-Tejada, J., Azpiroz, A., & Arregi, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.019 · Cited by 27
Metadata
- Authors
- Zhu, C.-B., Blakely, R. D., & Hewlett, W. A.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Hewlett, William A
- Venue
- Neuropsychopharmacology
- Published
- 2006-02-01
- Volume
- 31
- Issue
- 10
- Pages
- 2121-2131
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2065313926
- Cited by
- 549
- References
- 63
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 21 · 2023: 32 · 2022: 32 · 2021: 34 · 2020: 30 · 2019: 31 · 2018: 28 · 2017: 21 · 2016: 33 · 2015: 38 · 2014: 38 · 2013: 40 · 2012: 37
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institute on Drug Abuse (DA-07390, R01DA007390)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- serotonin transporter, IL-1β, TNF-α, inflammatory cytokines, p38 MAPK, serotonin uptake, serotonin, neuroinflammation, interleukin-1 receptor antagonist, SB203580, synaptosomes, midbrain, striatum
- MeSH terms
- Analysis of Variance, Animals, Cell Line, Corpus Striatum, Dose-Response Relationship, Drug, Drug Interactions, Enzyme Activation, Enzyme Inhibitors, Interleukin-1, Mesencephalon, Neurons, Raphe Nuclei, Serotonin, Synaptosomes, Tumor Necrosis Factor-alpha, p38 Mitogen-Activated Protein Kinases, Serotonin Plasma Membrane Transport Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review